Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
Oslo, Norway, 23 February 2023: Following the announcement on 16 February 2023 of a proposed convertible bond financing of up to NOK 300m with Atlas Special Opportunities ("Atlas"), and the subsequent EGM notice to approve the associated agreements, Targovax' management invites to a live webcast with a presentation of the main commercial terms and a subsequent Q&A session on Tuesday 28 February at 10am CET.
Date: Tuesday 28 February 2023
Time: 10:00 CET
Webcast click here for teams link (https://teams.microsoft.com/l/meetup
link: -join/19%3ameeting_NDIxNTRjYjQtZDAwMi00NjQwLWIwNWItZTFjZTY2MzUxM
GJm%4
0thre
ad.v2/0?context=%7b%22Tid%22%3a%2266b0661a-3ec3-48a8-a966
-5b0cce82b3fe%22%2c%22Oid%22%3a%22f1f4b1fb-51b3-4160-8c7e
-64dc6bdf46bb%22%7d)
Presenters: Erik Digman Wiklund, CEO and Lubor Gaal, CFO
Please submit any questions in advance to renate.birkeli@targovax.com (renate.birkeli@targovax.com?subject=Question(s)%20to%20live%20webcast%20Tuesday%2028th%20February%202023)or directly during the live webcast.
Questions will be accepted in both English and Norwegian and addressed in the respective language.